APRE - CIK 0001781983
The table below shows Aprea Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.60M | $22.85M | $21.61M | $28.79M | $53.08M | $89.02M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $15.56M |
| $23.58M |
| $22.52M |
| $30.15M |
| $56.58M |
| $92.42M |
| Property, plant & equipment | $59.81K | $81.52K | $88.36K | $2.32K | $23.87K | $38.52K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $15.93M | $23.98M | $22.65M | $30.16M | $56.82M | $92.81M |
| Accounts payable | $713.67K | $1.35M | $1.67M | $842.75K | $1.77M | $4.50M |
| Total current liabilities | $2.76M | $3.36M | $4.39M | $3.20M | $7.32M | $15.33M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | $3.20M | $7.32M | $15.41M |
| Retained earnings | -$333.64M | -$321.04M | -$308.08M | -$293.80M | -$181.13M | -$144.01M |
| Total equity | $12.44M | $19.31M | $16.95M | $25.64M | $49.51M | $77.40M |